by admin_63069 | Oct 1, 2025 | Related Topics
Changes in screening recommendations over a decade ago may have inadvertently resulted in later diagnosis of the most common cancer in men, a new study has found.
by admin_63069 | Sep 24, 2025 | Related Topics
The University of Chicago Medicine’s focal therapy program for prostate cancer has completed more than 300 procedures – a volume that ranks among the highest in the U.S.
by admin_63069 | Sep 17, 2025 | News You Can Use
Preclinical studies demonstrated tumor shrinkage and PSA decline with HLD-0915, showing a favorable therapeutic index, even in drug-resistant models.
by admin_63069 | Sep 10, 2025 | Related Topics
The new formulation should increase the batch size by approximately 50% and will offer the potential to expand access to patients in new geographic locations.
by admin_63069 | Sep 3, 2025 | News You Can Use
AI’s role in reviewing prior authorization requests and then denying claims in batches
